S. C. Schou
Table 5. Incorporation of deuterium observed using different rhodium sources
Entry
Rhodium source
%D
10.5 eq. Crabtree’s catalyst, %D
1
2
3
4
5
6
7
8
Rh black (Alfa Aesar)
Rh black (ABCR)
Rh black (Aldrich)
Rh (Acros)
19
16
16
0
93
50–57
91
0
0
90
Rh (Fluka)
0
5wt% Rh/act. aluminaa
5wt% Rh/aluminaa
5wt% Rh/carbona
75–92
71
88
93
85
aAdded amount correlates to 0.6 eq. rhodium. Experimental conditions: 1 (0.016 mmol), catalyst/catalysts, dry THF:DCM
(1:1)(3 mL), D2 (1550–1665 mbar), RT, 4 h.
4.0 Hz, 1H, C5-H), 7.34 (dd, J = 4.6 and 8.5 Hz, 1H, C4-H), 3.83
(s, 3H, OCH3).
Table 6. Incorporation of deuterium observed in different
solvents
Entry 14
1H NMR (600 MHz, DMSO-d6)d 8.70 (s, 1H, C2-H), 8.51 (s, 1H, C4-H).
Entry 15
% incorporation of deuterium
Entry
Solvent
No additive
10.5 e.q Crabtree’s
catalyst
1H NMR (600 MHz, DMSO-d6)d 7.04–6.94 (m, 2H, C3,5-H), 6.55
(dd, J = 5.5 and 13.1 Hz, 2H, C2,6-H), 6.48 (t, J = 7.3 Hz, 1H, C4-H),
4.98 (s, 2H, NH2).
1
2
3
4
5
Et2O
EtOAc
DCM
THF
0a
84
60
89
90–93c
Conclusion
A new catalytic system based on rhodium black with Crabtree’s
catalyst as an additive has been investigated. In general, the
mixture has an improved activity, compared with rhodium black
alone. In two cases neither Crabtree’s catalyst nor rhodium black
was able to promote exchange, but using the mixture an
incorporation of deuterium was observed. The new catalytic
system is active in a variety of solvents, extending the
usefulness. This protocol will, of course, also be useful when
tritiated compounds are needed. The scope of this new catalytic
system is currently being investigated further in our laboratories.
THF:DCM (1:1)
16b
a1 is slightly soluble in Et2O.
bExperiment performed in THF-d8:DCM-d2 show a similar
incorporation level (12%).
cExperiment performed in THF-d8:DCM-d2 show a slightly
decreased incorporation level (68%). Experimental condi-
tions: 1 (0.016 mmol), catalyst/catalysts, dry THF:DCM
(1:1)(3 mL), D2 (1418–1666 mbar), RT, 4 h.
Entry 8
Acknowledgement
1H NMR (500 MHz, DMSO-d6)d 8.64 (d, J = 5.0 Hz, 1H, C6-H),
7.88 (d, J = 1.0 Hz, 1H, C2-H), 7.85 (dd, J = 1.2 and 3.5 Hz, 1H,
C5-H), 3.91 (s, 3H, OCH3).
The author gratefully thanks Gunnar Grue-Sørensen (LEO
Pharma) for fruitful discussions and invaluable assistance
and support, the Department of Spectroscopy and Physical
Chemistry at LEO Pharma, especially Grethe Aagaard for NMR
assistance and Lone Møss and Else Kristoffersen for obtaining
high resolution NMR-spectra.
Entry 9
1H NMR (500 MHz, DMSO-d6)d 8.85 (dd, J = 1.6 and 4.4 Hz, 2H,
C2,6-H), 7.87 (dd, J = 1.7 and 4.4 Hz, 2H, C3,5-H).
Entry 10
1H NMR (600 MHz, DMSO-d6)d 8.69 (ddd, J = 1.0, 1.8 and
4.8 Hz, 1H, C6-H), 8.10 (dt, J = 1.8 and 3.2 Hz, 2H, Ph-C2,6-H), 7.97
(dt, J = 1.0 and 8.0 Hz, 1H, C4-H), 7.89 (td, J = 1.8 and 7.8 Hz, 1H,
C3-H), 7.54–7.48 (m, 2H, Ph-C3,5-H), 7.47–7.42 (m, 1H, Ph-C4-H),
7.36 (ddd, J = 1.1, 4.8 and 7.4 Hz, 1H, C5-H).
Entry 11
References
1H NMR (500 MHz, DMSO-d6)d 8.49 (dd, J = 0.8 and 4.8 Hz, 1H,
C6-H), 7.69 (td, J = 1.9 and 7.7 Hz, 1H, C4-H), 7.25 (t, J = 7.8 Hz, 1H,
C5-H), 7.18 (ddd, J = 1.1, 4.8 and 7.4 Hz, 1H, C3-H), 3.01 (hept,
J = 6.9 Hz, 1H, i-Pr-CH), 1.23 (d, J = 6.9 Hz, 6H, i-Pr-CH3).
Entry 12
[1] E. Alexakis, J. R. Jones, W. J. S. Lockley, Tetrahedron Lett. 2006, 47,
[2] G. J. Ellames, J. S. Gibson, J. M. Herbert, A. H. McNeill, Tetrahedron.
2001, 57, 9487–9497.
[3] J. S. Valsborg, L. Sørensen, C. Foged, J Label Compd Radiopharm.
[4] D. Hesk, P. R. Das, B. Evans, J Label Compd Radiopharm. 1995, 36,
[5] A. Y. L. Shu, D. Saunders, S. H. Levinson, S. W. Landvatter,
A. Mahoney, S. G. Senderoff, J. F. Mack, J. R. Heys, J Label Compd
Radiopharm. 1999, 42, 797–807.
1H NMR (500 MHz, MeOD)d 8.19 (s, 1H, C6-H), 7.66 (d,
J = 7.2 Hz, 1H, C4-H), 7.10 (d, J = 8.4 Hz, 1H, C3-H), 6.99–6.92 (m,
1H, C5-H).
Entry 13
1H NMR (500 MHz, DMSO-d6)d 8.31 (d, J = 2.9 Hz, 1H, C3-H),
8.18 (dd, J = 1.3 and 4.5 Hz, 1H, C6-H), 7.38 (ddd, J = 1.2, 2.2 and
[6] M. E. Powell, C. S. Elmore, P. N. Dorff, J. R. Heys, J Label Compd
Copyright r 2009 John Wiley & Sons, Ltd.
J. Label Compd. Radiopharm 2009, 52 376–381